Author:
Goury Antoine,Mourvillier Bruno
Subject
Pulmonary and Respiratory Medicine
Reference14 articles.
1. Global case fatality rate from COVID-19 has decreased by 96.8% during 2.5 years of the pandemic;Horita;J Med Virol,2023
2. Complement and its role in innate and adaptive immune responses;Dunkelberger;Cell Res,2010
3. JAK inhibition as a new treatment strategy for patients with COVID-19;Huang;Biochem Pharmacol,2022
4. Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial;Hall;Lancet Respir Med,2023
5. Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial;Annane;Lancet Respir Med,2023
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献